Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

SmithKline Beecham's C-DART approach to rheumatoid arthritis

May 17, 1996

Novel antiarthritics claimed by Procter & Gamble

May 17, 1996

British Biotech reveals metalloproteinase inhibitors

May 17, 1996

COX-2 inhibitors claimed by Searle

May 17, 1996

Hoechst claims treatment for chronic polyarthritis

May 10, 1996

FR-133605 effective in preclinical models of rheumatoid arthritis, septic shock

May 3, 1996

Fujisawa reports collagenase inhibitors

May 3, 1996

Searle and Yamanouchi to codevelop celecoxib

April 26, 1996

Hisamitsu discloses new cyclooxygenase inhibitor

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...